More accurate and cost-effective health management for the Greek citizen
Recent technological breakthroughs, such as rapid sequencing of the human genome and high-throughput profiling of epigenetic, metabolic and environmental influences in physiology and disease, have led to deeper understanding of the molecular basis of human pathologies, offering a unique potential to radically transform disease management in the coming decades. Personalised medicine/ healthcare (also known as stratified, precise or P4 medicine) has emerged as the next step in prevention and treatment of disease and refers to tailored medical treatments based on the individual characteristics of patients.
pMedGR aims to become a regional hub for the implementation, coordination and integration of personalized medicine approaches in South-East Europe, as part of a global network, offering centralized information on patient stratification, susceptibility factors and response to treatments for relevant regional populations. This hub will serve as a single entry point for researchers and industry with an interest in targeting this area. Greece’s strategic geopolitical position, which correlates with genetic characteristics that may be important to health and disease, render it ideal to serve as a paradigm for personalized approaches targeting an extended regional area, including south Italy, the Balkans, Turkey etc. Through pMedGR, Greece has the potential to become a South-East European Node for Personalized Medicine, linking Europe to emerging markets such as Asia, Africa and the Middle East.
Full implementation and operational capacity
Build-up of operational capacity
Optimisation of services and access policies
Transnational access services
Technology transfer protocols and IP exploitation
Public-private partnership building and investment recruitment
Building and laboratory space preparations
Procurement of high-end equipment and infrastructure development
Recruitment and training of research and technology personnel
Set up of new equipment and optimization of usage
Demonstration projects and pilot studies
Standard operating procedures and protocol development
Feasibility study and Business plan, including funding sources, governance plan, sustainability, legal form, operational capacity, access policy, management structure etc.
Mapping capacities and needs for the development of drug discovery pipelines by the academic, clinical and industrial community
Stakeholder and user network building (including initial MoU, public and private investor networks, fund mobilization